{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T11:11:55Z","timestamp":1742209915217,"version":"3.38.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301590","82371410"],"award-info":[{"award-number":["82301590","82371410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M742116"],"award-info":[{"award-number":["2023M742116"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH106","ZR2024MH231"],"award-info":[{"award-number":["ZR2023QH106","ZR2024MH231"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Postdoctoral Innovation Talent Support Program","award":["SDBX2022061"],"award-info":[{"award-number":["SDBX2022061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Mutations in the <jats:italic>TK2<\/jats:italic> gene are strongly associated with mitochondrial DNA depletion syndrome (MDS), a severe condition with high mortality and poor outcomes. Although many MDS cases are reported, those linked to <jats:italic>TK2<\/jats:italic> mutations with lipid deposition are rare. Large deletions in the <jats:italic>TK2<\/jats:italic> gene are even rarer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted whole-exome sequencing to find the gene linked to MDS, followed by genomic and structural analyses, histopathological, and functional analyses to assess the mutations' pathogenicity. Additionally, a HEK293T cell model with <jats:italic>TK2<\/jats:italic> mutations was created to investigate the impact of large deletions on mitochondrial function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The patient was found to have a novel compound heterozygous mutation in the <jats:italic>TK2<\/jats:italic> gene, consisting of a large deletion spanning exons 5\u201310 (E5-E10 del) and a previously reported missense mutation (c.311C\u2009&gt;\u2009A, p.Arg104His). Analysis of the patient's muscle tissue demonstrated a marked reduction in mtDNA content and a significant impairment in overall mitochondrial function. In the HEK293T cell model, the group with the deletion mutation exhibited a notable reduction in TK2 protein expression and levels of mitochondrial complex subunits when compared to the control group. Furthermore, there was an observed increase in ROS levels, a decrease in ATP production, and compromised mitochondrial respiratory chain function. Moreover, we conducted a comprehensive review of the previously reported genotypic and phenotypic spectrum of <jats:italic>TK2<\/jats:italic> mutations in the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This case report underscores the detrimental impact of large fragment deletion mutations in the <jats:italic>TK2<\/jats:italic> gene and elucidates their role in the pathogenesis of MDS. It broadens the spectrum of known <jats:italic>TK2<\/jats:italic> mutations and enhances our understanding of the structural and functional consequences of these mutations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03639-x","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T10:23:41Z","timestamp":1742207021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel biallelic TK2 mutations cause mitochondrial DNA depletion syndrome with infantile early-onset lipid storage myopathy"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9334-6702","authenticated-orcid":false,"given":"Duoling","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7120-6572","authenticated-orcid":false,"given":"Yixin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanhan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-5184","authenticated-orcid":false,"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-6749","authenticated-orcid":false,"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"3639_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","volume":"15","author":"S Rahman","year":"2019","unstructured":"Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nat Rev Neurol. 2019;15:40\u201352.","journal-title":"Nat Rev Neurol"},{"key":"3639_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/med.20124","volume":"28","author":"M-J P\u00e9rez-P\u00e9rez","year":"2008","unstructured":"P\u00e9rez-P\u00e9rez M-J, Priego E-M, Hern\u00e1ndez A-I, Familiar O, Camarasa M-J, Negri A, et al. Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future. Med Res Rev. 2008;28:797\u2013820.","journal-title":"Med Res Rev"},{"key":"3639_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ng2040","volume":"39","author":"A Bourdon","year":"2007","unstructured":"Bourdon A, Minai L, Serre V, Jais J-P, Sarzi E, Aubert S, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet. 2007;39:776\u201380.","journal-title":"Nat Genet"},{"key":"3639_CR4","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/brain\/awn236","volume":"131","author":"A G\u00f6tz","year":"2008","unstructured":"G\u00f6tz A, Isohanni P, Pihko H, Paetau A, Herva R, Saarenp\u00e4\u00e4-Heikkil\u00e4 O, et al. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain. 2008;131:2841\u201350.","journal-title":"Brain"},{"key":"3639_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s13311-013-0177-6","volume":"10","author":"AW El-Hattab","year":"2013","unstructured":"El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics. 2013;10:186\u201398.","journal-title":"Neurotherapeutics"},{"key":"3639_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mrrev.2016.04.009","volume":"769","author":"BB Ganguly","year":"2016","unstructured":"Ganguly BB, Kadam NN. Mutations of myelodysplastic syndromes (MDS): an update. Mutat Res Rev Mutat Res. 2016;769:47\u201362.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"3639_CR7","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1212\/NXG.0000000000000095","volume":"2","author":"T Termglinchan","year":"2016","unstructured":"Termglinchan T, Hisamatsu S, Ohmori J, Suzumura H, Sumitomo N, Imataka G, et al. Novel TK2 mutations as a cause of delayed muscle maturation in mtDNA depletion syndrome. Neurol Genet. 2016;2:e95.","journal-title":"Neurol Genet"},{"key":"3639_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ymgme.2013.07.009","volume":"110","author":"S Chanprasert","year":"2013","unstructured":"Chanprasert S, Wang J, Weng S-W, Enns GM, Bou\u00e9 DR, Wong BL, et al. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene. Mol Genet Metab. 2013;110:153\u201361.","journal-title":"Mol Genet Metab"},{"key":"3639_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.nmd.2005.03.010","volume":"15","author":"M Tulinius","year":"2005","unstructured":"Tulinius M, Moslemi A-R, Darin N, Holme E, Oldfors A. Novel mutations in the thymidine kinase 2 gene (TK2) associated with fatal mitochondrial myopathy and mitochondrial DNA depletion. Neuromuscul Disord. 2005;15:412\u20135.","journal-title":"Neuromuscul Disord"},{"key":"3639_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13578-020-00493-1","volume":"10","author":"EE Bitter","year":"2020","unstructured":"Bitter EE, Townsend MH, Erickson R, Allen C, O\u2019Neill KL. Thymidine kinase 1 through the ages: a comprehensive review. Cell Biosci. 2020;10:138.","journal-title":"Cell Biosci"},{"key":"3639_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3233\/JND-210786","volume":"9","author":"A Berardo","year":"2022","unstructured":"Berardo A, Dom\u00ednguez-Gonz\u00e1lez C, Engelstad K, Hirano M. Advances in thymidine kinase 2 deficiency: clinical aspects, translational progress, and emerging therapies. J Neuromuscul Dis. 2022;9:225\u201335.","journal-title":"J Neuromuscul Dis"},{"key":"3639_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13023-021-02030-w","volume":"16","author":"C Dom\u00ednguez-Gonz\u00e1lez","year":"2021","unstructured":"Dom\u00ednguez-Gonz\u00e1lez C, Madruga-Garrido M, Hirano M, Mart\u00ed I, Mart\u00edn MA, Munell F, et al. Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency. Orphanet J Rare Dis. 2021;16:407.","journal-title":"Orphanet J Rare Dis"},{"key":"3639_CR13","doi-asserted-by":"publisher","first-page":"e200138","DOI":"10.1212\/NXG.0000000000200138","volume":"10","author":"F Ceballos","year":"2024","unstructured":"Ceballos F, Serrano-Lorenzo P, Bermejo-Guerrero L, Bl\u00e1zquez A, Quesada-Espinosa JF, Amigo J, et al. Clinical and genetic analysis of patients with TK2 deficiency. Neurol Genet. 2024;10:e200138.","journal-title":"Neurol Genet"},{"key":"3639_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/15257771003729591","volume":"29","author":"B Munch-Petersen","year":"2010","unstructured":"Munch-Petersen B. Enzymatic regulation of cytosolic thymidine kinase 1 and mitochondrial thymidine kinase 2: a mini review. Nucleosides Nucleotides Nucleic Acids. 2010;29:363\u20139.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3639_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/15257770600894501","volume":"25","author":"C Desler","year":"2006","unstructured":"Desler C, Munch-Petersen B, Rasmussen LJ. The role of mitochondrial dNTP levels in cells with reduced TK2 activity. Nucleosides Nucleotides Nucleic Acids. 2006;25:1171\u20135.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3639_CR16","doi-asserted-by":"publisher","first-page":"18435","DOI":"10.1073\/pnas.1910574116","volume":"116","author":"W Qian","year":"2019","unstructured":"Qian W, Kumar N, Roginskaya V, Fouquerel E, Opresko PL, Shiva S, et al. Chemoptogenetic damage to mitochondria causes rapid telomere dysfunction. Proc Natl Acad Sci USA. 2019;116:18435\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3639_CR17","first-page":"e74","volume":"48","author":"X-J Lu","year":"2020","unstructured":"Lu X-J. DSSR-enabled innovative schematics of 3D nucleic acid structures with PyMOL. Nucleic Acids Res. 2020;48:e74.","journal-title":"Nucleic Acids Res"},{"key":"3639_CR18","doi-asserted-by":"publisher","first-page":"10785","DOI":"10.1093\/nar\/gkab792","volume":"49","author":"F Adikusuma","year":"2021","unstructured":"Adikusuma F, Lushington C, Arudkumar J, Godahewa GI, Chey YCJ, Gierus L, et al. Optimized nickase- and nuclease-based prime editing in human and mouse cells. Nucleic Acids Res. 2021;49:10785\u201395.","journal-title":"Nucleic Acids Res"},{"key":"3639_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"3639_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-023-01804-z","volume":"22","author":"M Jiang","year":"2023","unstructured":"Jiang M, Jike Y, Liu K, Gan F, Zhang K, Xie M, et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol Cancer. 2023;22:113.","journal-title":"Mol Cancer"},{"key":"3639_CR21","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1021\/acsnano.1c09818","volume":"16","author":"Y Liu","year":"2022","unstructured":"Liu Y, Lu Y, Ning B, Su X, Yang B, Dong H, et al. Intravenous delivery of living listeria monocytogenes elicits gasdmermin-dependent tumor pyroptosis and motivates anti-tumor immune response. ACS Nano. 2022;16:4102\u201315.","journal-title":"ACS Nano"},{"key":"3639_CR22","doi-asserted-by":"publisher","first-page":"10340","DOI":"10.1093\/nar\/gkz742","volume":"47","author":"X Zhao","year":"2019","unstructured":"Zhao X, Cui L, Xiao Y, Mao Q, Aishanjiang M, Kong W, et al. Hypertension-associated mitochondrial DNA 4401A>G mutation caused the aberrant processing of tRNAMet, all 8 tRNAs and ND6 mRNA in the light-strand transcript. Nucleic Acids Res. 2019;47:10340\u201356.","journal-title":"Nucleic Acids Res"},{"key":"3639_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ymgme.2018.04.012","volume":"124","author":"J Wang","year":"2018","unstructured":"Wang J, Kim E, Dai H, Stefans V, Vogel H, Al Jasmi F, et al. Clinical and molecular spectrum of thymidine kinase 2-related mtDNA maintenance defect. Mol Genet Metab. 2018;124:124\u201330.","journal-title":"Mol Genet Metab"},{"key":"3639_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/jmedgenet-2017-105012","volume":"55","author":"C Garone","year":"2018","unstructured":"Garone C, Taylor RW, Nascimento A, Poulton J, Fratter C, Dom\u00ednguez-Gonz\u00e1lez C, et al. Retrospective natural history of thymidine kinase 2 deficiency. J Med Genet. 2018;55:515\u201321.","journal-title":"J Med Genet"},{"issue":"44","key":"3639_CR25","doi-asserted-by":"publisher","first-page":"16212","DOI":"10.1073\/pnas.0604567103","volume":"103","author":"J Zhang","year":"2006","unstructured":"Zhang J, Frerman FE, Kim J-JP. Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool. Proceed Natl Acad Sci. 2006;103(44):16212\u20137. https:\/\/doi.org\/10.1073\/pnas.0604567103.","journal-title":"Proceed Natl Acad Sci"},{"key":"3639_CR26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/archneur.63.8.1122","volume":"63","author":"M Oskoui","year":"2006","unstructured":"Oskoui M, Davidzon G, Pascual J, Erazo R, Gurgel-Giannetti J, Krishna S, et al. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol. 2006;63:1122\u20136.","journal-title":"Arch Neurol"},{"key":"3639_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.nmd.2008.04.014","volume":"18","author":"E Blakely","year":"2008","unstructured":"Blakely E, He L, Gardner JL, Hudson G, Walter J, Hughes I, et al. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy. Neuromuscul Disord. 2008;18:557\u201360.","journal-title":"Neuromuscul Disord"},{"key":"3639_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nmd.2009.11.013","volume":"20","author":"N Lesko","year":"2010","unstructured":"Lesko N, Naess K, Wibom R, Solaroli N, Nennesmo I, von D\u00f6beln U, et al. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion. Neuromuscul Disord. 2010;20:198\u2013203.","journal-title":"Neuromuscul Disord"},{"key":"3639_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0887-8994(96)00118-X","volume":"15","author":"R Pons","year":"1996","unstructured":"Pons R, Andreetta F, Wang CH, Vu TH, Bonilla E, DiMauro S, et al. Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol. 1996;15:153\u20138.","journal-title":"Pediatr Neurol"},{"key":"3639_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1203\/PDR.0b013e3181e33bbe","volume":"68","author":"R Mart\u00ed","year":"2010","unstructured":"Mart\u00ed R, Nascimento A, Colomer J, Lara MC, L\u00f3pez-Gallardo E, Ruiz-Pesini E, et al. Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and a novel mutation in the TK2 gene. Pediatr Res. 2010;68:151\u20134.","journal-title":"Pediatr Res"},{"key":"3639_CR31","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/oby.2009.152","volume":"17","author":"J Villarroya","year":"2009","unstructured":"Villarroya J, Giralt M, Villarroya F. Mitochondrial DNA: an up-and-coming actor in white adipose tissue pathophysiology. Obesity (Silver Spring). 2009;17:1814\u201320.","journal-title":"Obesity (Silver Spring)"},{"key":"3639_CR32","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/JOE-19-0295","volume":"243","author":"J Villarroya","year":"2019","unstructured":"Villarroya J, Cereijo R, Gavald\u00e0-Navarro A, Peyrou M, Giralt M, Villarroya F. New insights into the secretory functions of brown adipose tissue. J Endocrinol. 2019;243:R19-27.","journal-title":"J Endocrinol"},{"issue":"1","key":"3639_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1172\/JCI114409","volume":"85","author":"NJ Watmough","year":"1990","unstructured":"Watmough NJ, Bindoff LA, Birch-Machin MA, Jackson S, Bartlett K, Ragan CI, Poulton J, Gardiner RM, Sherratt HS, Turnbull DM. Impaired mitochondrial beta-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. J Clin Invest. 1990;85(1):177\u201384. https:\/\/doi.org\/10.1172\/JCI114409.","journal-title":"J Clin Invest"},{"key":"3639_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ana.24922","volume":"81","author":"C Lopez-Gomez","year":"2017","unstructured":"Lopez-Gomez C, Levy RJ, Sanchez-Quintero MJ, Juanola-Falgarona M, Barca E, Garcia-Diaz B, et al. Deoxycytidine and deoxythymidine treatment for thymidine kinase 2 deficiency. Ann Neurol. 2017;81:641\u201352.","journal-title":"Ann Neurol"},{"key":"3639_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ebiom.2019.07.037","volume":"46","author":"C Lopez-Gomez","year":"2019","unstructured":"Lopez-Gomez C, Hewan H, Sierra C, Akman HO, Sanchez-Quintero MJ, Juanola-Falgarona M, et al. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency. EBioMedicine. 2019;46:356\u201367.","journal-title":"EBioMedicine"},{"key":"3639_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ana.25506","volume":"86","author":"C Dom\u00ednguez-Gonz\u00e1lez","year":"2019","unstructured":"Dom\u00ednguez-Gonz\u00e1lez C, Madruga-Garrido M, Mavillard F, Garone C, Aguirre-Rodr\u00edguez FJ, Donati MA, et al. Deoxynucleoside therapy for thymidine kinase 2-deficient myopathy. Ann Neurol. 2019;86:293\u2013303.","journal-title":"Ann Neurol"},{"key":"3639_CR37","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1017\/S1047951116001876","volume":"27","author":"S Mazurova","year":"2017","unstructured":"Mazurova S, Magner M, Kucerova-Vidrova V, Vondrackova A, Stranecky V, Pristoupilova A, et al. Thymidine kinase 2 and alanyl-tRNA synthetase 2 deficiencies cause lethal mitochondrial cardiomyopathy: case reports and review of the literature. Cardiol Young. 2017;27:936\u201344.","journal-title":"Cardiol Young"},{"key":"3639_CR38","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.nmd.2014.05.009","volume":"24","author":"S Roos","year":"2014","unstructured":"Roos S, Lindgren U, Ehrstedt C, Moslemi AR, Oldfors A. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations. Neuromuscul Disord. 2014;24:713\u201320.","journal-title":"Neuromuscul Disord"},{"key":"3639_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1212\/WNL.0b013e31827f0ff7","volume":"80","author":"C Paradas","year":"2013","unstructured":"Paradas C, Guti\u00e9rrez R\u00edos P, Rivas E, Carbonell P, Hirano M, DiMauro S. TK2 mutation presenting as indolent myopathy. Neurology. 2013;80:504\u20136.","journal-title":"Neurology"},{"key":"3639_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/humu.9135","volume":"21","author":"R Carrozzo","year":"2003","unstructured":"Carrozzo R, Bornstein B, Lucioli S, Campos Y, de la Pena P, Petit N, et al. Mutation analysis in 16 patients with mtDNA depletion. Hum Mutat. 2003;21:453\u20134.","journal-title":"Hum Mutat"},{"key":"3639_CR41","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/1093526616686439","volume":"20","author":"E Mart\u00edn-Hern\u00e1ndez","year":"2017","unstructured":"Mart\u00edn-Hern\u00e1ndez E, Garc\u00eda-Silva MT, Quijada-Fraile P, Rodr\u00edguez-Garc\u00eda ME, Rivera H, Hern\u00e1ndez-La\u00edn A, et al. Myopathic mtDNA depletion syndrome due to mutation in TK2 gene. Pediatr Dev Pathol. 2017;20:416\u201320.","journal-title":"Pediatr Dev Pathol"},{"key":"3639_CR42","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1212\/01.wnl.0000436931.94291.e6","volume":"81","author":"CL Alston","year":"2013","unstructured":"Alston CL, Schaefer AM, Raman P, Solaroli N, Krishnan KJ, Blakely EL, et al. Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions. Neurology. 2013;81:2051\u20133.","journal-title":"Neurology"},{"key":"3639_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejpn.2007.09.005","volume":"12","author":"E Leshinsky-Silver","year":"2008","unstructured":"Leshinsky-Silver E, Michelson M, Cohen S, Ginsberg M, Sadeh M, Barash V, et al. A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion. Eur J Paediatr Neurol. 2008;12:309\u201313.","journal-title":"Eur J Paediatr Neurol"},{"key":"3639_CR44","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1212\/WNL.0b013e318248df2b","volume":"78","author":"A B\u00e9hin","year":"2012","unstructured":"B\u00e9hin A, Jardel C, Claeys KG, Fagart J, Louha M, Romero NB, et al. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum. Neurology. 2012;78:644\u20138.","journal-title":"Neurology"},{"key":"3639_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13023-019-1071-z","volume":"14","author":"C Dom\u00ednguez-Gonz\u00e1lez","year":"2019","unstructured":"Dom\u00ednguez-Gonz\u00e1lez C, Hern\u00e1ndez-La\u00edn A, Rivas E, Hern\u00e1ndez-Voth A, Sayas Catal\u00e1n J, Fern\u00e1ndez-Torr\u00f3n R, et al. Late-onset thymidine kinase 2 deficiency: a review of 18 cases. Orphanet J Rare Dis. 2019;14:100.","journal-title":"Orphanet J Rare Dis"},{"key":"3639_CR46","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3389\/fneur.2020.01000","volume":"11","author":"C Hu","year":"2020","unstructured":"Hu C, Li X, Zhao L, Shi Y, Zhou S, Wang Y. Clinical profile and outcome of pediatric mitochondrial myopathy in China. Front Neurol. 2020;11:1000.","journal-title":"Front Neurol"},{"key":"3639_CR47","first-page":"94","volume":"39","author":"GK Papadimas","year":"2020","unstructured":"Papadimas GK, Vargiami E, Dragoumi P, Van Coster R, Smet J, Seneca S, et al. Mild myopathic phenotype in a patient with homozygous c.416C > T mutation in TK2 gene. Acta Myol. 2020;39:94\u20137.","journal-title":"Acta Myol."},{"key":"3639_CR48","doi-asserted-by":"publisher","first-page":"100701","DOI":"10.1016\/j.ymgmr.2020.100701","volume":"26","author":"C Pablo","year":"2021","unstructured":"Pablo C, Mor\u00eds G, Jim\u00e9nez-Mallebrera C, Badosa C, Hern\u00e1ndez-La\u00edn A, Encinar AB, Mart\u00edn M\u00c1, Dom\u00ednguez-Gonz\u00e1lez C. Recurrent rhabdomyolysis and exercise intolerance: a new phenotype of late-onset thymidine kinase 2 deficiency. Mol Genet Metab Rep. 2021;26:100701. https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100701.","journal-title":"Mol Genet Metab Rep"},{"key":"3639_CR49","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.3390\/ijms22115598","volume":"22","author":"S Laine-Men\u00e9ndez","year":"2021","unstructured":"Laine-Men\u00e9ndez S, Dom\u00ednguez-Gonz\u00e1lez C, Bl\u00e1zquez A, Delmiro A, Garc\u00eda-Consuegra I, Fern\u00e1ndez-de la Torre M, et al. Preferent diaphragmatic involvement in TK2 deficiency: an autopsy case study. Int J Mol Sci. 2021;22:5598.","journal-title":"Int J Mol Sci"},{"key":"3639_CR50","doi-asserted-by":"publisher","first-page":"857279","DOI":"10.3389\/fneur.2022.857279","volume":"13","author":"A Manini","year":"2022","unstructured":"Manini A, Meneri M, Rodolico C, Corti S, Toscano A, Comi GP, et al. Case report: thymidine kinase 2 (TK2) deficiency: a novel mutation associated with childhood-onset mitochondrial myopathy and atypical progression. Front Neurol. 2022;13:857279.","journal-title":"Front Neurol"},{"key":"3639_CR51","first-page":"381","volume":"56","author":"Y Wu","year":"2018","unstructured":"Wu Y, Liu DH, Zhang XX. Thymidine kinase 2 gene compound heterozygous mutation leads to mitochondrial DNA depletion syndrome-2:a case report. Zhonghua Er Ke Za Zhi. 2018;56:381\u20132.","journal-title":"Zhonghua Er Ke Za Zhi"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03639-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T10:40:25Z","timestamp":1742208025000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03639-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3639"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03639-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Shandong University Qilu Hospital (approval no. KYLL-2021(KS)-079).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}